| Autor: |
Kumar Gupta S; Department of General Practice and Emergency Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal., Jyotsana P; Kathmandu Medical College, Sinamangal, Kathmandu, Nepal., Singh A; Kathmandu Medical College, Sinamangal, Kathmandu, Nepal., Phuyal D; Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal., Allam P; Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal. |
| Abstrakt: |
With the surge of cases during the second wave of COVID-19 in Nepal, a number of mucormycosis coinfection cases have also come to our attention. We present a case of a 65-year-old female who was admitted to our emergency department with complaints of pain, swelling, and tingling sensation of the left side of the face along with blood-tinged nasal discharge for 20 days. She had been tested positive for COVID-19 a month back and managed with oxygen support and corticosteroids. Magnetic Resonance Imaging showed invasive fungal sinusitis, with the positive black turbinate sign and mild extension along with the dura mater of the left temporal lobe, and left cavernous sinus. She was diagnosed with rhinocerebral mucormycosis and managed with systemic antifungal therapy and insulin. As per the treatment modality, surgical debridement could not be done because the patient did not give consent. |
